{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:06:06Z","timestamp":1789185966395,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejso.2026.111777","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:14:11Z","timestamp":1774599251000},"page":"111777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["First preclinical evaluation of a thermogel delivering mitomycin C: sustained local release with preserved surgical safety in a large animal model"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-004X","authenticated-orcid":false,"given":"Christian","family":"Mouawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Thouvenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Pimpie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Kaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-4293","authenticated-orcid":false,"given":"Veronique","family":"Kemmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-4929","authenticated-orcid":false,"given":"Clarisse","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Boudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mignet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4793-0008","authenticated-orcid":false,"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111777_bib1","series-title":"StatPearls","article-title":"Peritoneal metastasis","author":"Desai","year":"2024"},{"issue":"1","key":"10.1016\/j.ejso.2026.111777_bib2","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0102","article-title":"Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: surgeon's perspective","volume":"3","author":"Franko","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"12","key":"10.1016\/j.ejso.2026.111777_bib3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111777_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1245\/s10434-012-2473-5","article-title":"Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review","volume":"20","author":"Honor\u00e9","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111777_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111777_bib6","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","author":"Goodman","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111777_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"de Bree","year":"2017","journal-title":"Pleura Peritoneum"},{"issue":"1","key":"10.1016\/j.ejso.2026.111777_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12885-019-5545-0","volume":"19","author":"Rovers","year":"2019","journal-title":"BMC Cancer"},{"issue":"20","key":"10.1016\/j.ejso.2026.111777_bib9","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111777_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1245\/s10434-017-6037-6","article-title":"Locally advanced colorectal cancer: true peritoneal tumor penetration is associated with peritoneal metastases","volume":"25","author":"Klaver","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111777_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.critrevonc.2016.01.017","article-title":"Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review","volume":"100","author":"Baratti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111777_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/pp-2017-0003","article-title":"Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice","volume":"2","author":"Van der Speeten","year":"2017","journal-title":"Pleura Peritoneum"},{"issue":"7","key":"10.1016\/j.ejso.2026.111777_bib13","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.111777_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"Klaver","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111777_bib15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111777_bib16","doi-asserted-by":"crossref","unstructured":"Arjona-S\u00e1nchez A, Espinosa-Redondo E, Guti\u00e9rrez-Calvo A, et al. Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced Colon cancer: a phase 3 randomized clinical trial. JAMA Surg. Published online April 26, 2023:e230662. doi:10.1001\/jamasurg.2023.0662.","DOI":"10.1001\/jamasurg.2023.3486"},{"issue":"6","key":"10.1016\/j.ejso.2026.111777_bib17","first-page":"1088","article-title":"Reduction of carcinomatosis risk using icodextrin as a carrier solution of intraperitoneal oxaliplatin chemotherapy","volume":"43","author":"Jouvin","year":"2017","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111777_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejpb.2020.10.011","article-title":"Thermosensitive hydrogels for local delivery of 5-fluorouracil as neoadjuvant or adjuvant therapy in colorectal cancer","volume":"157","author":"Al Sabbagh","year":"2020","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV"},{"issue":"6","key":"10.1016\/j.ejso.2026.111777_bib19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/10781552211020808","article-title":"Stability of calcium levofolinate, 5-fluorouracil and oxaliplatin (FOLFOX) mixture","volume":"28","author":"Al Sabbagh","year":"2022","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"key":"10.1016\/j.ejso.2026.111777_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejpb.2021.01.020","article-title":"Combination of tumor cell anti-adhesion and anti-tumor effect to prevent recurrence after cytoreductive surgery in a mice model","volume":"169","author":"Seguin","year":"2021","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV"},{"issue":"4","key":"10.1016\/j.ejso.2026.111777_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bulcan.2018.02.001","article-title":"[Dihydropyrimidine d\u00e9hydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: update and recommendations of the French GPCO-Unicancer and RNPGx networks]","volume":"105","author":"Loriot","year":"2018","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.ejso.2026.111777_bib22","article-title":"Intraperitoneal administration of a thermogel combined with an anticancer agent for the prevention of peritoneal carcinomatosis in a pig model","volume":"28","author":"Thouvenin","year":"2024","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111777_bib23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1186\/s13063-022-06880-y","volume":"23","author":"Di Giorgio","year":"2022","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.ejso.2026.111777_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051324","volume":"12","author":"Pacelli","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejso.2026.111777_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fmed.2015.00088","article-title":"Therapeutic efficacy of Alpha-RIT using a (213)Bi-Anti-hCD138 antibody in a mouse model of ovarian peritoneal carcinomatosis","volume":"2","author":"Derrien","year":"2015","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.ejso.2026.111777_bib26","first-page":"431","article-title":"Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection","volume":"1","author":"Elias","year":"2000","journal-title":"Int J Surg Invest"},{"issue":"1","key":"10.1016\/j.ejso.2026.111777_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9","article-title":"Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy","volume":"92","author":"Elias","year":"2001","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2026.111777_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"3","key":"10.1016\/j.ejso.2026.111777_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00464-007-9423-5","article-title":"Use of hyaluronidase cream to prevent peritoneal adhesions in laparoscopic ventral hernia repair by means of intraperitoneal mesh fixation using spiral tacks","volume":"22","author":"Mart\u00edn-Cartes","year":"2008","journal-title":"Surg Endosc"},{"issue":"Suppl 3","key":"10.1016\/j.ejso.2026.111777_bib30","doi-asserted-by":"crossref","first-page":"S873","DOI":"10.1245\/s10434-015-4679-9","article-title":"Mitomycin C pharmacokinetics as predictor of severe neutropenia in hyperthermic intraperitoneal therapy","volume":"22","author":"Kemmel","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.111777_bib31","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1248\/cpb.40.2224","article-title":"Antitumor effect of pluronic F-127 gel containing mitomycin C on sarcoma-180 ascites tumor in mice","volume":"40","author":"Miyazaki","year":"1992","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"5","key":"10.1016\/j.ejso.2026.111777_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10611869708995844","article-title":"Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice","volume":"4","author":"Fujita","year":"1997","journal-title":"J Drug Target"},{"issue":"3","key":"10.1016\/j.ejso.2026.111777_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10585-023-10210-0","article-title":"Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model","volume":"40","author":"Wintjens","year":"2023","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ejso.2026.111777_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113763","article-title":"The pharmacokinetic profile of mitomycin C released from an injectable supramolecular hydrogel in a rodent model","volume":"383","author":"Wintjens","year":"2025","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"10","key":"10.1016\/j.ejso.2026.111777_bib35","first-page":"2076","article-title":"Evaluation of the effect of an intraperitoneal cytostatic-loaded supramolecular hydrogel on intestinal anastomotic healing in an animal model","volume":"13","author":"Heuvelings","year":"2023","journal-title":"Life Basel Switz"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326003963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326003963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:09:07Z","timestamp":1789182547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326003963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0748798326003963"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111777","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First preclinical evaluation of a thermogel delivering mitomycin C: sustained local release with preserved surgical safety in a large animal model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111777"}}